Comments
Indoco Remedies has received a warning letter from the United States Food and Drug Administration for its Goa plant. The US drug regulator had inspected the facility in Goa during August 31-September 4, 2016. Following this, the facility was handed down six observations in Form 483, which do not pertain to data integrity, Indoco Remedies disclosed to the stock exchanges. Shares of the company may react adversely to the development.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.